Yamaguchi, Takenori <br/><br/>
Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT).  [electronic resource] 

 -  Stroke  Jul 2006 
 - 1810-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4628 
<br/><br/><label>Standard No.: </label>10.1161/01.STR.0000227191.01792.e3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Brain Ischemia--drug therapy<br/>Cerebral Hemorrhage--chemically induced<br/>Cohort Studies<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Europe--epidemiology<br/>Female<br/>Fibrinolytic Agents--administration & dosage<br/>Humans<br/>Infusions, Intravenous<br/>Injections, Intravenous<br/>Intracranial Embolism--drug therapy<br/>Japan--epidemiology<br/>Male<br/>Middle Aged<br/>North America--epidemiology<br/>Prospective Studies<br/>Thrombolytic Therapy--adverse effects<br/>Time Factors<br/>Tissue Plasminogen Activator--administration & dosage<br/>Treatment Outcome